Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:H
TSX:HElectric Utilities

Will Crawford Connection Engineering Deals Reframe Hydro One's (TSX:H) Role in Ontario’s Electrification Story?

Earlier this week, Canada Nickel Company Inc. announced it had signed two Ontario Energy Board-approved agreements with Hydro One Networks to begin detailed engineering and design work to connect the Crawford Nickel Project north of Timmins to Hydro One’s Porcupine Station, including procurement of key 230kV equipment. This step underscores Hydro One’s role as a critical grid enabler for large-scale resource projects, aligning its transmission build-out with Ontario’s mining and...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

PTC (PTC) Valuation Check After Recent Share Price Weakness And SaaS Transition Progress

PTC stock performance snapshot PTC (PTC) shares closed at US$157.46, with the stock showing a 1 day return of 1.05% and a past week move of 4.13% decline. Over the past month, returns show a 3.23% decline. See our latest analysis for PTC. Zooming out, PTC’s recent share price returns, including a 10.53% decline over 90 days and a 7.43% decline year to date, contrast with its 1 year total shareholder return of 2.71% and 3 year total shareholder return of 31.80%. This suggests longer term...
ASX:TLX
ASX:TLXBiotechs

Telix Pharmaceuticals (ASX:TLX) Is Up 11.3% After Positive Phase 3 TLX591-Tx Safety Data - What's Changed

In early March 2026, Telix Pharmaceuticals reported that Part 1 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer met its primary safety and dosimetry objectives, with an acceptable tolerability profile and no new safety signals across combinations with standard-of-care therapies. A distinctive aspect for investors is that TLX591-Tx’s antibody-based design showed minimal kidney, salivary and lacrimal gland exposure versus existing...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Is Align Technology (ALGN) Pricing Look Attractive After Recent Share Price Pullback

If you are wondering whether Align Technology's current share price offers good value or too much optimism, you are not alone in asking that question right now. The stock closed at US$166.92, with a 7 day return of a 4.9% decline and a 30 day return of a 15.0% decline. It still shows a 7.0% gain year to date and a 4.0% return over 1 year, set against a much steeper 48.9% decline over 3 years and a 67.5% decline over 5 years. Recent headlines around Align have focused on its position in clear...
XTRA:HNR1
XTRA:HNR1Insurance

Hannover Rück (XTRA:HNR1) Valuation Check After Full Year Results And Earnings Driven Share Price Gain

Earnings announcement puts Hannover Rück (XTRA:HNR1) in focus Hannover Rück (XTRA:HNR1) released its full year 2025 results, reporting net income of €2,641.5m and basic earnings per share of €21.9, along with its Q4 2025 earnings call on March 12, 2026. See our latest analysis for Hannover Rück. The earnings release appears to have been a catalyst, with the 1-day share price return of 4.45% lifting Hannover Rück to €258.4, building on a 30-day share price return of 6.69% even as the 1-year...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

A Look At Cooper Companies (COO) Valuation After Recent Share Price Weakness

What recent moves in Cooper Companies (COO) might mean for investors Cooper Companies (COO) has been under pressure recently, with the share price showing declines over the past week, month, and past 3 months. This may prompt investors to reassess the current valuation and fundamentals. See our latest analysis for Cooper Companies. At a share price of US$71.52, Cooper Companies has seen pressure build recently, with a 30-day share price return of 12.32% and a 1-year total shareholder return...
NasdaqCM:TSSI
NasdaqCM:TSSIIT

TSS (TSSI) Is Up 34.0% After AI-Focused Integration Fuels Strong 2025 Earnings Beat - What's Changed

TSS, Inc. reported past fourth-quarter 2025 results with revenue rising to US$60.91 million and net income to US$12.16 million, lifting diluted EPS from continuing operations to US$0.41 versus US$0.08 a year earlier. For 2025 as a whole, TSS, Inc. nearly doubled revenue to US$245.72 million and lifted diluted EPS from continuing operations to US$0.56, underscoring how expanded AI-focused systems integration and facilities management work is translating into higher profitability. With...
NYSE:R
NYSE:RTransportation

Is Ryder System (R) Still Fairly Priced After Recent Share Price Pullback

If you are wondering whether Ryder System at around US$187 is still attractively priced, you are not alone. The stock’s recent run puts valuation questions front and center. The share price is down 11.1% over the past week and 11.9% over the past month, even though the 1 year return sits at 39.9% and the 3 year return at 132.7%. Recent interest around Ryder has been shaped by ongoing discussion of its role in transportation and logistics services, especially as investors weigh how freight...
SEHK:1810
SEHK:1810Tech

Is Xiaomi (SEHK:1810) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Xiaomi's current share price gives you good value or not, it helps to separate the story from the numbers and look at what the valuation data is actually saying. The stock last closed at HK$33.30, with returns of 3.4% over the past week, a 6.4% decline over the last month, a 17.3% decline year to date, a 37.0% decline over 1 year, and a 205.5% gain over 3 years, alongside a 27.1% gain over 5 years. Recent coverage has focused on Xiaomi's position as a major...
NYSE:KKR
NYSE:KKRCapital Markets

A Look At KKR (KKR) Valuation After Recent Share Price Weakness

Why KKR stock is drawing attention now KKR (KKR) is back on many investors’ watchlists after a stretch of weak share performance, with the stock showing negative returns over the past week, month, past 3 months and year. See our latest analysis for KKR. That recent 3.7% one day share price decline and 21.8% 30 day share price pullback at around US$83.88 sit alongside a 22.3% 1 year total shareholder return decline, while the 3 and 5 year total shareholder returns of 72.4% and 83.1% present a...
NYSE:ZIM
NYSE:ZIMShipping

ZIM Sale To Hapag Lloyd Puts Cash Value On Cyclical Earnings Profile

ZIM Integrated Shipping Services (NYSE:ZIM) agreed to be acquired by Hapag-Lloyd in an all-cash deal valued at about US$4.2b. The offer, endorsed unanimously by ZIM's board, comes at a premium to the recent trading price of NYSE:ZIM shares. The transaction includes carve outs to meet Israeli government requirements, keeping local control of ZIM branding and select vessels. Closing is subject to shareholder approval and regulatory clearances across multiple jurisdictions. ZIM Integrated...
NYSE:TEL
NYSE:TELElectronic

Assessing TE Connectivity (TEL) Valuation After Dividend Hike And Expanded Buyback Program

TE Connectivity (TEL) highlighted capital returns after its board approved a 10% increase in the quarterly dividend to US$0.78 per share and added US$3.0b to its share repurchase authorization. See our latest analysis for TE Connectivity. Even with the new dividend and expanded US$3.0b buyback plan, TE Connectivity’s short term share price momentum has cooled, with a 30 day share price return of -12.37% and year to date share price return of -15.17%, while the 1 year total shareholder return...
TSX:CNQ
TSX:CNQOil and Gas

Is It Too Late To Consider Canadian Natural Resources (TSX:CNQ) After A 68% One-Year Surge?

Wondering if Canadian Natural Resources at around $66 per share still offers value, or if most of the easy gains are already behind it? This article walks through the numbers so you can judge how the current price stacks up against underlying worth. The stock last closed at $66.17, with returns of 6.8% over the past 7 days, 24.8% over 30 days, 40.4% year to date, 68.5% over 1 year, 116.8% over 3 years and a very large gain over 5 years of 354.6%. Recent attention around Canadian energy...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

Is It Too Late To Consider CG Oncology (CGON) After A 143% One Year Surge?

If you are wondering whether CG Oncology's current share price still offers value after a strong run, you are not alone. This article is designed to help you frame that question clearly. CG Oncology last closed at US$62.97, with reported returns of 4.3% over the past week, 18.6% over the past month, 50.7% year to date and 142.7% over the past year. These figures naturally raise questions about how expectations and risk are now being priced in. Recent interest in CG Oncology has been driven...
OM:LATO B
OM:LATO BIndustrials

Assessing Latour’s (OM:LATO B) Valuation After SEK1.5b In New Bond Issues

Investment AB Latour (OM:LATO B) has raised SEK 1,500 million through three new bond loans under its existing MTN program. This financing move puts the group’s capital structure and funding choices in focus for shareholders. See our latest analysis for Investment AB Latour. Latour’s latest bond issue comes at a time when the share price, now at SEK206.6, has seen a 9.66% 1 month share price decline and a 25.92% 1 year total shareholder return decline, pointing to fading momentum despite a...
NYSE:WM
NYSE:WMCommercial Services

Assessing Waste Management (WM) Valuation After Earnings Miss, Insider Selling And Dividend Declaration

Dividend declaration in focus after earnings-driven share price drop Waste Management (WM) has come under closer scrutiny after a recent share price drop following slightly below forecast fourth quarter results, insider selling and mixed commentary on its near term outlook. At the same time, the company has declared a quarterly cash dividend of $0.945 per share, payable on March 27, 2026, to shareholders of record on March 13, 2026, keeping income considerations in the spotlight. See our...
OB:MOWI
OB:MOWIFood

Is Mowi (OB:MOWI) Pricing Reflect Recent Aquaculture Regulations And Long Term Return Potential?

If you are wondering whether Mowi shares still offer fair value at around kr222.40, you are not alone. Many investors are asking what the current price actually reflects. The stock is roughly flat over the last week with a 0.6% decline, and it is down 1.2% over the last month and 8.9% year to date, while the 1 year and 3 year returns of 15.4% and 37.0% show that long term holders have seen a very different experience. Recent coverage around Mowi has focused on its position as a major salmon...
NYSE:UBER
NYSE:UBERTransportation

How Uber’s Wayve and Nissan Robotaxi Deal Could Reshape Uber Technologies (UBER) Investors’ Long-Term Narrative

In recent days, Wayve, Uber, and Nissan finalized a memorandum of understanding to develop robotaxis, targeting a late-2026 pilot in Tokyo using Nissan LEAF vehicles powered by Wayve’s AI Driver and accessed via Uber’s platform. This collaboration, alongside Uber’s broader autonomous partnerships, underlines the company’s push to be the software and demand layer for self-driving fleets rather than owning the vehicles and hardware itself. We’ll now examine how Uber’s push to be the...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

Is AGNC Investment (AGNC) Attractive After Recent P/E Discount And Share Price Volatility

If you are wondering whether AGNC Investment is priced attractively today, the key question is how its current share price compares with a fair value estimate using different valuation tools. The stock last closed at US$10.39, with returns of a 4.7% decline over 7 days, a 7.4% decline over 30 days, a 4.9% decline year to date, but a 19.6% gain over 1 year, a 62.9% gain over 3 years and a 22.9% gain over 5 years. This gives you a mixed picture of shorter term pressure and longer term...
NYSE:VTOL
NYSE:VTOLEnergy Services

Is It Time To Reassess Bristow Group (VTOL) After Its Recent Share Price Pullback

Investors may be wondering if Bristow Group at around US$42.99 is offering good value right now, or if the recent run has already priced in the key positives. The stock has pulled back over the last week and month, with 7 day and 30 day returns of a 3.5% decline and a 4.0% decline, but it still sits on gains of 15.1% year to date, 39.0% over the past year, 95.9% over three years, and 67.0% over five years. Recent attention on Bristow Group has been driven by its role within the energy and...
NYSE:BKV
NYSE:BKVOil and Gas

A Look At BKV (BKV) Valuation After Its $257.6 Million Follow On Equity Offering

BKV (BKV) has just completed a follow on equity offering of 9,692,089 common shares, raising about $257.6 million. This is a key capital event that comes as energy prices and the stock both move lower. See our latest analysis for BKV. That equity raise comes on the heels of a recent pullback, with a 1 day share price return of 1.82%, a 7 day share price return of 9.22% and a 30 day share price return of 7.21%, even as the 1 year total shareholder return sits at 47.17%. This suggests that...
NYSE:NOC
NYSE:NOCAerospace & Defense

Is It Too Late To Consider Northrop Grumman (NOC) After A 52% One Year Rally?

Investors may be wondering if Northrop Grumman's current share price reflects its underlying value, or if the stock might be priced away from its fundamentals. The stock last closed at US$736.30, with returns of 7.5% over 30 days, 25.7% year to date and 52.5% over the past year. Recent coverage has focused on Northrop Grumman's role as a major U.S. defense contractor and its exposure to long term government programs. This helps frame how investors think about the stock's risk and cash flow...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

Is Nutex Health’s (NUTX) New Buyback and ESOP Shelf Quietly Redefining Its Capital Strategy?

Nutex Health Inc. recently reported full-year 2025 results showing revenue of US$875.26 million and net income of US$70.79 million, and also authorized a new US$25 million share repurchase program alongside a US$99.31 million shelf registration for 1,100,000 common shares tied to an ESOP-related offering. The combination of stronger profitability metrics and a fresh buyback plan, set against potential future stock issuance, highlights how Nutex Health is actively managing both its capital...
NYSE:COHR
NYSE:COHRElectronic

A Look At Coherent (COHR) Valuation After S&P 500 Inclusion And US$2b NVIDIA AI Deal

Coherent (COHR) has been in focus after news it will join the S&P 500 on March 23, alongside a multiyear supply agreement and US$2b investment from NVIDIA tied to AI optical networking. See our latest analysis for Coherent. The recent S&P 500 inclusion news and NVIDIA agreement come after a powerful run, with a 90 day share price return of 35.29% and a 1 year total shareholder return above 7x. However, the 7 day share price return of 4.96% and 1 day move of 4.03% show some near term cooling,...